Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform.
Mol Ther Oncolytics. 2021 Feb 10;20:459-469. doi: 10.1016/j.omto.2021.02.006. eCollection 2021 Mar 26.
Mol Ther Oncolytics. 2021.
PMID: 33718594
Free PMC article.
A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella.
Fusciello M, Ylösmäki E, Feola S, Uoti A, Martins B, Aalto K, Hamdan F, Chiaro J, Russo S, Viitala T, Cerullo V.
Fusciello M, et al. Among authors: uoti a.
Mol Ther Oncolytics. 2022 Apr 19;25:137-145. doi: 10.1016/j.omto.2022.04.002. eCollection 2022 Jun 16.
Mol Ther Oncolytics. 2022.
PMID: 35572195
Free PMC article.
Item in Clipboard
Efflux and uptake transport and gut microbial reactivation of raloxifene glucuronides.
Uoti A, Kurkela M, Niemi M, Oksanen T, Oswald S, Puustinen L, Kidron H, Sjöstedt N.
Uoti A, et al.
Basic Clin Pharmacol Toxicol. 2025 Jan;136(1):e14107. doi: 10.1111/bcpt.14107.
Basic Clin Pharmacol Toxicol. 2025.
PMID: 39702747
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.